Assistant Professor, Microbiology & Immunology, Study Director, Regulated Studies, Institutional Office of Regulated Nonclinical Studies, UT Medical Branch at Galveston
Mail Box: Rte 0184, Rebecca Sealy, Room No.: 2.810
Dr. Brasel's interests lie in the strategic planning and execution of preclinical studies that evaluate medical countermeasures (vaccines and therapeutics) toward FDA licensure. He is currently focused on the implementation of quality systems and regulatory processes in A/BSL-4 laboratories. To date, no vaccines or therapeutics have been approved for human use against BSL-4 agents (e.g., Ebola and Marburg viruses). Through collaborations with world experts (many of whom reside at UTMB) in parallel with independently led studies. Dr. Brasel's ultimate goal is FDA approval of high profile medical countermeasures specific for biodefense-related and emerging diseases.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
GCC Consortium for Antimicrobial Resistance (GCC AMR)
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.